Although this difference did not reach statistical significance due to small sample size, the trend may suggest an association between capecitabine response and immune-activated tumor microenvironment characteristics.
← all excerpts
TBKBP1 induces capecitabine resistance through negative regulation of type I interferon pathway in triple-negative breast cancer.
1
—
—